Patients with rheumatoid arthritis in clinical care

被引:58
|
作者
Smolen, JS
Aletaha, D
机构
[1] Univ Vienna, Vienna Gen Hosp Vienna, Dept Internal Med 3, Div Rheumatol, A-1090 Vienna, Austria
[2] Lainz Hosp, Dept Med 2, Vienna, Austria
关键词
D O I
10.1136/ard.2003.012575
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Taken together, our current clinical armamentarium to follow the course of RA offers several disease activity measures. Evaluation of radiographic destruction, but also of anatomical changes such as malalignment,77 can serve as outcome measure, because these changes best reflect the damage related to the pathological process in and around the joints; whether radiological changes can be reversible, is still a matter of debate. 78 Assessment of function reflects the combination of disease activity and damage. Questionnaires or other instruments which only determine functional improvement due to irreversible damage are not (yet) available. However, their development could lead to interesting, new clinical insights. Likewise, basic science has not yet provided us with tests that reflect the destructive process reliably. Measuring disease activity by surrogate measures such as the acute phase proteins does not reflect destruction at a single point in time. In conclusion, assessment of disease activity, damage, and functional capacity are equally important also in clinical practice; RA, if insufficiently controlled, may be a highly destructive disease. Achieving low disease activity, ideally a remission-like state, is pivotal to improving prognosis. 79 Current treatments and early institution of DMARDs allow this aim to be accomplished in many patients. However, decisions to switch (or to maintain) treatment require recording of the patients' clinical status, and in many healthcare systems the use of costly treatments, as increasingly employed, requires justification which, again, can only come from recorded data. 18 Rather than guessing disease activity and quality of life, providing evidence will validate decisions and improve quality of care. A combination of a more physician centred activity score, such as the SDAI or similar, with a patient centred functional measure, such as the HAQ or similar, in conjunction with an occasional evaluation of the radiographic situation, will give all necessary information for the longitudinal observation of patients' disease state in clinical practice. The tools are available and so relatively easy to use.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 50 条
  • [21] CLINICAL VASCULITIS IN RHEUMATOID-ARTHRITIS PATIENTS
    INAGAKI, K
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1980, 39 : 60 - 63
  • [22] Clinical and Epidemiological Characterization of Patients with Rheumatoid Arthritis
    Gonzalez Otero, Zoe Alina
    Egueez Mesa, Jorge Luis
    Fuste Jimenez, Celestino
    Reyes Medina, Eugenio Alejandro
    Borges Lopez, Jose Alberto
    Gonzalez Otero, Lazaro Hermes
    FINLAY, 2015, 5 (04): : 264 - 274
  • [23] Rheumatoid arthritis patients' participation in clinical trials
    Rachel Murphy
    Nature Clinical Practice Rheumatology, 2006, 2 (3): : 123 - 123
  • [24] CLINICAL EFFICACY OF STATINS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Mikulets, L.
    Ilashchuk, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1167 - 1167
  • [25] The clinical utility of accelerometry in patients with rheumatoid arthritis
    Prioreschi, Alessandra
    Hodkinson, Bridget
    Avidon, Ingrid
    Tikly, Mohammed
    McVeigh, Joanne A.
    RHEUMATOLOGY, 2013, 52 (09) : 1721 - 1727
  • [26] The evolution of biomarkers in rheumatoid arthritis: From clinical research to clinical care
    van den Broek, Theodorus
    Tesser, John R. P.
    Albani, Salvatore
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (11) : 1773 - +
  • [27] Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care
    Pincus, T
    Sokka, T
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2003, 17 (05): : 753 - 781
  • [28] IMPACT OF SEVERITY INDEX FOR RHEUMATOID ARTHRITIS ON HEALTH CARE COSTS AND UTILIZATIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Baser, O.
    Wang, L.
    Du, J.
    Wang, H.
    Xie, L.
    VALUE IN HEALTH, 2012, 15 (07) : A441 - A441
  • [29] Remote pharmaceutical care for patients with rheumatoid arthritis and psoriasis
    Martinez-Santana, V.
    Boix-Montanes, A.
    Fernandez-Canabate, E.
    Gonzalez-Melarde, B.
    Miserachs-Aranda, N.
    Modamio-Charles, P.
    Fernandez-Lastra, C.
    Marino-Hernandez, E.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (04) : 938 - 947
  • [30] COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN AN INDIGENOUS CARE CLINIC
    Santoyo Fexas, Leticia
    Garza Elizondo, C. Mario Alberto
    Elizondo Solis, Cesar Vidal
    Moreno Salinas, Andrea
    Castaneda Martinez, Martha Mariana
    Galarza Delgado, Med. Dionicio Angel
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 65 - 65